Imunon Inc (NASDAQ:IMNN) does about 10.04M shares in volume on a normal day but saw 19136092 shares change hands in the recent trading day. The company now has a market cap of 44.03M USD. Its current market price is $2.51, marking an increase of 0.80% compared to the previous close of $2.49. The 52 week high reached by this stock is $3.65 whilst the lowest price level in 52 weeks is $0.37.
The consensus objective for the share price is $11.20, suggesting that the stock has a potential upside of 77.59% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The current price level is 138.19%, 156.85%, and 164.54% away from its SMA20, SMA50, and SMA200 respectively, with the IMNN price moving below the 50-day SMA on current market day. Imunon Inc (IMNN) stock is up 116.38% over the week and 198.81% over the past month. Its price is 164.21% year-to-date and 69.59% over the past year.
To reach the target analysts have set, the stock logically needs to grow 77.59 percent from here.
Outstanding shares total 17.54M with insiders holding 1.52% of the shares and institutional holders owning 2.35% of the company’s common stock. The company has a return on investment of -1670.41% and return on equity of -397.54%. The beta has a value of 2.14. Price to book ratio is 81.18.
